Get the Stockscreener App
3.58
3.47%
0.12
Biomerica Inc stock is traded at $3.58, with a volume of 10,185.
It is up +3.47% in the last 24 hours and down -16.84% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$3.46
Open:
$3.61
24h Volume:
10,185
Relative Volume:
0.13
Market Cap:
$9.19M
Revenue:
$5.51M
Net Income/Loss:
$-6.16M
P/E Ratio:
-9.6757
EPS:
-0.37
Net Cash Flow:
$-5.03M
1W Performance:
-0.83%
1M Performance:
-16.84%
6M Performance:
+14.74%
1Y Performance:
-27.09%
1-Day Range:
$3.4699
$3.61
1-Week Range:
$3.261
$3.95
52-Week Range:
$1.932
$10.16
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
3.58 | 9.19M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
Biomerica, Inc. and CLIA Laboratory Partner Filed for inFoods IBS Test - marketscreener.com
Biomerica submits application for PLA code for inFoods IBS diagnostic test - TipRanks
Biomerica (BMRA) Seeks New CPT Code for IBS Diagnostic Test | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS TestA Key Step Toward Reimbursement - The Manila Times
PLA Code Application Filed for inFoods IBS Test -- A Key Step Toward Reimbursement | BMRA Stock News - GuruFocus
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement - Stock Titan
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Biomerica (NASDAQ:BMRA) Stock Price Crosses Below Two Hundred Day Moving Average – Time to Sell? - American Banking and Market News
Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry - TipRanks
Biomerica (BMRA) Gains UAE Approval for Fortel Ulcer Test | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - The Manila Times
United Arab Emirates Ministry of Health and Prevention Approves - GuruFocus
BMRA Stock Might Surge: Biomerica’s New Ulcer Test Now Available Across the UAE - Own Snap
United Arab Emirates Ministry Of Health And Prevention Approves Biomerica'S Fortel® Ulcer Test For Detection Of H. Pylori Infection - marketscreener.com
Biomerica Secures Major UAE Approval for Rapid H. Pylori Test as Middle East Expansion Accelerates - Stock Titan
BMRA stock touches 52-week high of $3.84 amid market fluctuations - Investing.com
Financial Health Report: Biomerica Inc (BMRA)’s Ratios Tell a Tale - DWinneX
BMRA stock touches 52-week high of $3.84 amid market fluctuations By Investing.com - Investing.com South Africa
Biomerica’s kidney disease test gains approval for sale in UAE - Yahoo Finance
Biomerica stock plummets on 1-for-8 reverse stock split - MSN
Biomerica’s kidney disease test approved for UAE market By Investing.com - Investing.com Canada
Walmart to Expand Sales of BiomericaÆS Aware Breast Self Exam; Product Will Now Be Available in over 2400 Walmart Stores - marketscreener.com
Biomerica (BMRA) Gains UAE Approval for Fortel Kidney Disease Te - GuruFocus
BiomericaFortel Kidney Disease Test Approved For Sale In UAE - marketscreener.com
Biomerica’s kidney disease test approved for UAE market - Investing.com Australia
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - The Manila Times
Revolutionary 10-Minute Test Could Help Detect Hidden Kidney Disease in 80% of At-Risk Patients - Stock Titan
Biomerica Stock Set to Reverse Split on Monday, April 21st (NASDAQ:BMRA) - Defense World
Biomerica announces reverse stock split - Medical Buyer
Biomerica announces reverse stock split to meet Nasdaq requirements - Investing.com Australia
Biomerica announces reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Crude Oil Moves Higher; Travelers Earnings Beat Estimates - Benzinga
Biomerica Announced 1-for-8 Reverse Stock Split - Nasdaq
Biomerica Plans Reverse Stock Split to Regain Nasdaq Listing Compliance - marketscreener.com
Biomerica Announces 1-for-8 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings - Benzinga
Biomerica (BMRA) Announces 1-for-8 Reverse Stock Split Effective April 2025 | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split Effective April 21 - TipRanks
Biomerica, Inc. Announces 1-for-8 Reverse Stock Split Effective April 21, 2025 - Nasdaq
Biomerica's Strategic 1:8 Reverse Split Aims to Secure Nasdaq Future - Stock Titan
3 High-Value Companies With Triple-Digit Upside Potential - The Globe and Mail
Biomerica Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
Biomerica Reports Third Quarter Fiscal 2025 Financial Results | - GuruFocus
Biomerica (BMRA) Reports Q3 Revenue Increase and Lower Expenses - GuruFocus
Wheat Losses Continuing on Tuesday Morning - The Globe and Mail
Biomerica Turns Corner: 10% Growth, Cost Cuts, and Major Regulatory Wins Boost Q3 Results - Stock Titan
BIOMERICA INC SEC 10-Q Report - TradingView
La Mancha Investment buying more Belo Sun Mining (BSX) - The Globe and Mail
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):